Loading clinical trials...
Loading clinical trials...
Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy in the First-line Anti-Helicobacter Pylori Treatment
Conditions
Interventions
vonoprazan, tripotassium dicitrate bismuthate, amoxicilline
rabeprazole, tripotassium dicitrate bismuthate, tetracycline, metronidazole
Locations
1
Taiwan
Kaohsiung Medical University Hospital
Kaohsiung City, Taiwan
Start Date
October 21, 2025
Primary Completion Date
November 15, 2027
Completion Date
December 31, 2027
Last Updated
January 22, 2026
NCT07537634
NCT07516262
NCT07335406
NCT07179159
NCT07293910
NCT04191551
Lead Sponsor
Kaohsiung Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions